Geographical distribution of systemic sclerosis in Canada: An ecologic study based on the Canadian Scleroderma Research Group

被引：2
|
作者：
Muntyanu, Anastasiya [1 ]
Ouchene, Lydia [2 ]
Zhou, Siriu [3 ]
Hudson, Marie [3 ,4 ]
Rezaeian, Mohsen [5 ]
LaChance, Avery [6 ]
Litvinov, Ivan V. [1 ]
Baron, Murray [4 ]
Netchiporouk, Elena [1 ]
机构：
[1] McGill Univ, Dept Med, Ctr Hlth, Div Dermatol, 1650 Ave Cedar, Montreal, PQ H3G 1A4, Canada
[2] McGill Univ, Fac Med, Ctr Hlth, Montreal, PQ, Canada
[3] McGill Univ, Lady Davis Inst, Jewish Gen Hosp, Montreal, PQ, Canada
[4] Jewish Gen Hosp, Div Rheumatol, Dept Med, Montreal, PQ, Canada
[5] Rafsanjan Univ Med Sci, Sch Med, Dept Epidemiol & Biostat, Occupat Environm Res Ctr, Rafsanjan, Iran
[6] Harvard Med Sch, Dept Dermatol, Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 87卷 / 05期
关键词：
Canada; environmental factors; epide-miology; geographic distribution; prevalence; scleroderma; systemic sclerosis; EPIDEMIOLOGY;
D O I：
10.1016/j.jaad.2021.12.055
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：1095 / 1097
页数：3
相关论文
共 50 条
  • [21] Scleroderma Presentation in the Canadian Scleroderma Research Group Indigenous Population
    Sobchak, Curtis
    Beattie, Karen
    Larche, Maggie
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (07) : 778 - 778
  • [22] Scleroderma Presentation in the Canadian Scleroderma Research Group Indigenous Population
    Sobchak, Curtis
    Beattie, Karen
    Larche, Maggie
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3880 - 3881
  • [23] Association of C-reactive protein with high disease activity in systemic sclerosis: Results from the Canadian Scleroderma Research Group
    Muangchan, Chayawee
    Harding, Sarah
    Khimdas, Sarit
    Bonner, Ashley
    Baron, Murray
    Pope, Janet
    ARTHRITIS CARE & RESEARCH, 2012, 64 (09) : 1405 - 1414
  • [24] ASSOCIATIONS WITH DIGITAL ULCERS (DU) IN A LARGE COHORT OF SYSTEMIC SCLEROSIS (SSC): RESULTS FROM THE CANADIAN SCLERODERMA RESEARCH GROUP (CSRG)
    Pope, J.
    Khimdas, S.
    Harding, S.
    Bonner, A.
    Baron, C. S. R. G. M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S91 - S91
  • [25] Sociodemographic and clinical correlates of fatigue in patients with systemic sclerosis: Evidence from 482 Canadian Scleroderma Research Group Registry patients
    Thombs, Brett
    Bassel, Marielle
    Hudson, Marie
    Taillefer, Suzanne
    Baron, Murray
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (06) : 1186 - 1186
  • [26] What is the relationship between disease activity, severity and damage in a large Canadian systemic sclerosis cohort? Results from the Canadian Scleroderma Research Group (CSRG)
    Fan, Xiangning
    Pope, Janet
    Baron, Murray
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (09) : 1205 - 1210
  • [27] What is the relationship between disease activity, severity and damage in a large Canadian systemic sclerosis cohort? Results from the Canadian Scleroderma Research Group (CSRG)
    Xiangning Fan
    Janet Pope
    Murray Baron
    Rheumatology International, 2010, 30 : 1205 - 1210
  • [28] Sex and time to diagnosis in systemic sclerosis: an updated analysis of 1,129 patients from the Canadian Scleroderma Research Group Registry
    Delisle, V. C.
    Hudson, M.
    Baron, M.
    Thombs, B. D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (06) : S10 - S14
  • [29] Sociodemographic, Disease, and Symptom Correlates of Fatigue in Systemic Sclerosis: Evidence From a Sample of 659 Canadian Scleroderma Research Group Registry Patients
    Thombs, Brett D.
    Hudson, Marie
    Bassel, Marielle
    Taillefer, Suzanne S.
    Baron, Murray
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (07): : 966 - 973
  • [30] Interstitial lung disease is associated with an increased risk of lung cancer in systemic sclerosis: Longitudinal data from the Canadian Scleroderma Research Group
    Sakr, Lama
    Hudson, Marie
    Wang, Mianbo
    Younanian, Elie
    Baron, Murray
    Bernatsky, Sasha
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2018, 3 (03) : 221 - 227
12345